Accropeutics Closes RMB100 Million Series B+ Round to Advance Inflammatory Disease Pipeline
Accropeutics Inc., a clinical-stage biotech company with operations in New York, US, and Suzhou, China,...
Accropeutics Inc., a clinical-stage biotech company with operations in New York, US, and Suzhou, China,...
Accro Bioscience (Suzhou) limited, better known as Accropeutics, a clinical-stage biotech operating out of New...
Accropeutics Inc., a clinical-stage biotechnology company with operations in New York, US, and Suzhou, China,...
Suzhou-based Accro Bioscience (Suzhou) Limited (Accropeutics) has announced that it has received approval from the...